Pharmacovigilating cardiotoxicity of immune checkpoint inhibitors

Lancet Oncol. 2018 Dec;19(12):1545-1546. doi: 10.1016/S1470-2045(18)30622-3. Epub 2018 Nov 12.

Authors

Gilda Varricchi¹, Maria Rosaria Galdiero¹, Valentina Mercurio¹, Domenico Bonaduce¹, Gianni Marone¹, Carlo G Tocchetti²

Affiliations

¹ Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research, World Allergy Organization Center of Excellence, Federico II University, Naples 80131, Italy.
² Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research, World Allergy Organization Center of Excellence, Federico II University, Naples 80131, Italy. Electronic address: [email protected].

PMID: 30442496
DOI: 10.1016/S1470-2045(18)30622-3

No abstract available

Publication types

Comment

MeSH terms

Cardiotoxicity*
Humans
Immunotherapy
Neoplasms*
Pharmacovigilance
Retrospective Studies